GHK-Cu Explained: Copper Coordination, Proposed Mechanisms and Research Applications

GHK-Cu is glycyl-L-histidyl-L-lysine bound to copper(II). The tripeptide occurs naturally in human plasma, binds copper ions with remarkable affinity and has been investigated for over half a century in extracellular matrix, wound-repair and skin research. Copper is not an optional extra here but part of what defines the compound. A GHK-Cu vial is clearly blue, a colour produced by the coordinated Cu(II) ion itself, so anything sold under this name that turns up as white powder is the free peptide rather than the copper complex.

This guide covers the discovery of GHK, the way copper is coordinated, the mechanisms proposed, the research fields in which it features and how the material should be specified and handled. We supply GHK-Cu exclusively for laboratory and formulation research.

Origin and structure: a copper-carrying tripeptide from plasma

Loren Pickart identified GHK in the early 1970s while investigating why plasma from young donors acted differently from that of older donors in liver tissue culture. The active fraction turned out to be the tripeptide glycyl-histidyl-lysine, and later studies showed its activity depended on copper. Plasma levels are reported to fall considerably with age, often quoted as about 200 ng/mL in a person's twenties and roughly 80 ng/mL by their sixties, and this observation is the basis of much of the later aging literature.

The peptide's copper affinity is built into its structure. Three donor atoms form a roughly square-planar binding site around Cu(II): the imidazole nitrogen of histidine, the free alpha-amino group of the N-terminal glycine and a deprotonated backbone amide nitrogen. The complex is stable enough to keep copper bound in the circulation yet labile enough to pass it to stronger cellular binders such as albumin and copper chaperone proteins. It is this mix of tight binding and exchangeability that sets a copper peptide apart from an inert copper salt.

In practice the complex and the free tripeptide are two different products. Free GHK is white, with a molecular weight close to 340 g/mol, whereas the copper complex is blue and weighs 403.93 g/mol. They cannot be swapped in an experiment, and colour is the quickest identity check you have.

Proposed mechanisms

No dedicated receptor for GHK-Cu has been confirmed, and the mechanisms described in the literature act on several levels simultaneously.

Copper transport and redox chemistry

The most tangible hypothesis is that GHK serves as a physiological copper shuttle, bringing Cu(II) to cells and to enzymes that need it. Lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase both require copper, so a delivery role could plausibly link the peptide to matrix maturation and redox balance without any specific receptor.

Matrix signalling

Fibroblast culture studies report greater synthesis of collagen, elastin, glycosaminoglycans and proteoglycans with GHK-Cu, along with shifts in matrix metalloproteinases and their tissue inhibitors. The overall picture is one of orchestrated remodelling, combining synthesis with regulated breakdown, rather than straightforward build-up.

Gene expression

Another line of work relies on whole-transcriptome profiling. Analyses of GHK-treated cultured cells describe changes in very many genes, concentrated in matrix, repair and antioxidant pathways. These datasets are broad and hypothesis-generating, and all the normal caveats about reading expression signatures from cell culture apply.

Hair follicle research

Follicle organ culture and rodent studies have looked at follicle size and hair-cycle phase, and this is where GHK-Cu overlaps with related copper tripeptides such as AHK-Cu. The two are set side by side in GHK-Cu vs AHK-Cu.

In fairness, GHK-Cu has an extensive, long-standing and predominantly in-vitro literature, plus cosmetic formulation studies, but relatively little controlled human trial evidence of the kind needed to support any clinical claim.

Areas of research

Skin and matrix (cell, ex vivo and some human formulation studies). Fibroblast collagen production, dermal matrix composition and cosmetic formulation studies that measure skin surface parameters. This is by far the largest applied literature.

Wound-repair models (rodent, ex vivo). Work since the 1980s has assessed closure rate, new vessel formation and recruitment of inflammatory cells in animals.

Hair. Follicle culture and animal studies, generally fewer in number than those on skin.

Aging and gene expression. The fall in plasma GHK with age is the starting point for studies using expression profiling and cellular senescence endpoints.

Formulation science. Copper complexes react with common cosmetic ingredients, especially strong reducing agents and some chelators, so there is a practical literature on stability, pH ranges and compatibility. It is directly useful for anyone working with the GHK-Cu serum, cream or scalp solution formats.

Formats and vial sizes

We stock raw GHK-Cu in lyophilized vials of 50 mg (€60), 100 mg (€90) and 200 mg (€155). These are far bigger than usual peptide vials for a simple reason: formulation and topical-model studies use tens of milligrams at a time rather than a few micrograms. At 403.93 g/mol, 100 mg is about 248 micromoles, a very substantial molar amount. Finished formats and the rest of the copper range are listed under copper peptides, and purchasing checks are set out in our GHK-Cu buying guide.

Reconstitution and storage in the lab

The maths is easy, and the numbers are large. Dissolving a 100 mg vial in 10 mL of diluent gives 10 mg/mL, i.e. 10,000 mcg/mL or roughly 24.8 mM. Because a 1% w/v solution is by definition 10 mg/mL, GHK-Cu is one of the few peptides whose stock concentrations translate directly into formulation percentages.

Three handling points apply specifically to the copper complex. The solution should be blue, and fading colour means the complex is breaking down. Copper(II) is redox-active, so keep it away from strong reducing agents and from chelators that would pull the metal off the peptide. And pH matters more than usual, since the binding site depends on a deprotonated backbone amide; strongly acidic conditions weaken the complex. Store the lyophilized powder at −20 °C protected from light and moisture; keep solutions refrigerated, shielded from light and split into aliquots so no single container is repeatedly warmed and cooled. Further advice is in the peptide storage guide.

Purity and reading the COA

Every lot is purified by reversed-phase HPLC to at least 99% and comes with a certificate tied to the vial's lot number. GHK-Cu needs one check most peptides do not: proof that the material is genuinely the copper complex. Colour is the first sign and the stated molecular weight the second, 403.93 g/mol for the complex against about 340 g/mol for free tripeptide. If copper content is given as a percentage, compare it with the theoretical figure for a 1:1 complex. The usual checks also apply: look for one well-resolved chromatographic peak instead of trusting the headline number, make sure the lot number matches the vial, and see whether net peptide content is reported separately from gross weight. Our COA reading guide explains these steps.

Regulatory position

GHK-Cu is used in finished cosmetic products in many markets, including the EU, but the raw material we supply is not an authorised medicine, not a food supplement and not a finished cosmetic. It is research-grade material for laboratory and formulation work by qualified researchers. Published skin and matrix findings come from cell systems, animal models and cosmetic formulation studies and are not therapeutic claims.

Related compounds and further reading

AHK-Cu is the nearest structural relative in our catalogue, and the comparison linked above covers both in detail. For broader context, read the peptides for skin research overview, and for the molecule's history, our long-form article on fifty years of copper peptide research.